Home / Business and Economy / India Pharma Exports Surge: Brazil & Nigeria Lead Growth
India Pharma Exports Surge: Brazil & Nigeria Lead Growth
18 Jan
Summary
- Brazil and Nigeria are now key export destinations for Indian pharmaceuticals.
- Pharmaceutical exports rose by 6.5% to $20.48 billion in April-November FY26.
- India's pharma exports show growing reliance on generics in emerging economies.
India's pharmaceutical exports demonstrated robust growth, reaching $20.48 billion between April and November of FY26. This represents a 6.5% increase, driven significantly by emerging markets like Brazil and Nigeria, which are becoming key destinations for Indian drug manufacturers.
Nigeria alone contributed over 14% to the total export growth, adding $179 million, while Brazil saw nearly $100 million in increased exports. This trend underscores the rising demand for Indian generics, fueled by expanding healthcare access and public procurement in these high-growth regions.
While the United States continues to be the largest market, accounting for over 31% of exports, the overall growth profile reveals a broadening demand across diverse geographies, including steady increases from countries like France, the Netherlands, Canada, Germany, and South Africa. This balanced export architecture strengthens India's position as a reliable global pharmaceutical supplier.
